Nathalie Boyer

Nathalie Boyer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Nathalie Boyer sits on this spectrum.

Nathalie Boyer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Nathalie Boyer sits on this spectrum.

Best Publications

• Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis

  Rami Moucari;Tarik Asselah;Dominique Cazals–Hatem;Hélène Voitot

  729
  Citations

• Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C

  Michele Martinot-Peignoux;Patrick Marcellin;Michele Pouteau;Corinne Castelnau

  706
  Citations

• Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients.

  Rami Moucari;Rami Moucari;Vincent Mackiewicz;Olivier Lada;Olivier Lada;Marie-Pierre Ripault;Marie-Pierre Ripault

  679
  Citations

• Fibrosis and disease progression in hepatitis C

  Patrick Marcellin;Tarik Asselah;Nathalie Boyer

  579
  Citations

• Recombinant human α‐interferon in patients with chronic non‐A, non‐B hepatitis: A multicenter randomized controlled trial from France

  Patrick Marcellin;Nathalie Boyer;Emile Giostra;Claude Degott

  467
  Citations

• Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis.

  Ana-Carolina Cardoso;Rami Moucari;Claudio Figueiredo-Mendes;Marie-Pierre Ripault

  441
  Citations

• The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

  Vincent Di Martino;Pierre Rufat;Nathalie Boyer;Philippe Renard

  428
  Citations

• Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C

  Sarah Maylin;Sarah Maylin;Michelle Martinot–Peignoux;Michelle Martinot–Peignoux;Rami Moucari;Nathalie Boyer

  410
  Citations

• Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers.

  Michelle Martinot-Peignoux;Nathalie Boyer;Magalie Colombat;Rahouda Akremi

  312
  Citations

• Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up.

  Corinne Castelnau;Frédéric Le Gal;Marie-Pierre Ripault;Emmanuel Gordien

  300
  Citations

• Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C

  Tarik Asselah;Ivan Bieche;Stéphanie Narguet;Audrey Sabbagh

  298
  Citations

• Pathogenesis, diagnosis and management of hepatitis C

  Nathalie Boyer;Patrick Marcellin

  291
  Citations

• Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives.

  Tarik Asselah;Nathalie Boyer;David Saadoun;Michele Martinot-Peignoux

  280
  Citations

• Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B

  Vincent di Martino;Thierry Thevenot;Jean–François Colin;Nathalie Boyer

  276
  Citations

• Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin.

  Michelle Martinot-Peignoux;Christiane Stern;Sarah Maylin;Marie-Pierre Ripault

  237
  Citations

• High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study.

  Rami Moucari;Anneke Korevaar;Anneke Korevaar;Olivier Lada;Olivier Lada;Michelle Martinot-Peignoux;Michelle Martinot-Peignoux

  236
  Citations

• Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA.

  Michelle Martinot-Peignoux;Nathalie Boyer;Dominique Cazals-Hatem;Bach-Nga Pham

  229
  Citations

• IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C

  Tarik Asselah;Simon De Muynck;Philippe Broët;Julien Masliah-Planchon;Julien Masliah-Planchon

  214
  Citations

• Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C.

  Ana-Carolina Cardoso;Roberto J. Carvalho-Filho;Roberto J. Carvalho-Filho;Christiane Stern;Alexandrine Dipumpo

  199
  Citations

• Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C

  Laure Elkrief;Pascale Chouinard;Noelle Bendersky;David Hajage

  196
  Citations